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Abstract
Evaluation of HIV-induced IL-2 production by peripheral blood mono-
nuclear cells (PBMC) and HIV-specific T helper and cytotoxic T
lymphocyte (CTL) responses in health care workers (HCW) occupa-
tionally exposed to HIV reveals a high rate of response to HIV among
non-seroconverters. IL-10 is also known to interfere with HIV infec-
tion in vitro. To evaluate the induction of IL-10 by HIV antigens in
HCW occupationally exposed to HIV, 18 HCW with percutaneous
injury were enrolled in this study, 9 of them exposed to HIV-contami-
nated blood, and 9 exposed to HIV-negative blood. PBMC were
incubated on plates coated with HIV-1 antigens, and IL-10 was
measured in supernatants by ELISA. Five of nine HCW exposed to
HIV-contaminated blood presented HIV-induced IL-10. Two of nine
HCW exposed to HIV-negative source patients also had detectable
levels of HIV-induced IL-10, one of them in the sample obtained on
the day of accidental exposure. There was a relationship between the
type of device involved in injury and IL-10 production. Individuals
exposed to hollow needles or scalpels presented HIV-induced IL-10,
whereas those exposed to solid needles and to digital puncture did not,
suggesting a relationship between infectious load and IL-10. Al-
though occupational exposure to HIV leads to a low rate of serocon-
version, these individuals can develop an antigen-specific immune
response characterized in our study by induction of IL-10 in PBMC in
vitro.
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The rate of HIV infection of health care
workers (HCW) associated with occupational
exposure to contaminated blood or body flu-
ids is estimated to be 0.3% (1). Risk factors
associated with higher rates of HIV-1 trans-
mission are deep injury, visible blood in the
device involved in the accident, procedures
involving needles in arteries or veins, and
terminal illness of the source patient (2).
Despite the low rate of seroconversion,
HCW frequently develop an HIV-specific
response following occupational exposure.
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HIV-specific production of interleukin (IL)-
2 and cytotoxic T lymphocyte (CTL) activity
has been demonstrated in HCW accidentally
exposed to HIV, suggesting that the contact
with the virus may be more frequent than
expected, and the immune response is possi-
bly a major determinant of protection against
HIV infection in this setting (3-5).
IL-10 is a cytokine derived from mono-
cytes, B and T lymphocytes that is a potent
macrophage deactivator (6). The role of this
cytokine in HIV infection has been the sub-
ject of many studies. Although it has been
shown that as the disease progresses IL-10
may be involved in the down-regulation of
the immune response (7), there is also evi-
dence that IL-10 may protect macrophages
from HIV-1 infection in vitro (8). Interest-
ingly, the enhancement of HIV-1 replication
in macrophages has also been attributed to
IL-10 (9).
The aims of the present study were to
evaluate the production of IL-10 by periph-
eral blood mononuclear cells (PBMC) from
HCW occupationally exposed to HIV-1 in
response to HIV antigens and to evaluate the
relationship between the presence of HIV-
induced IL-10 production and the character-
istics of each accident.
Eighteen HCW were enrolled in the study
between July 1997 and February 1998. The
research was approved by the University
Ethics Committee and written informed con-
sent was obtained from all participants. The
volunteers were recruited from Hospital São
Paulo, the University Hospital of Universi-
dade Federal de São Paulo (UNIFESP). Nine
HCW had been percutaneously exposed to
blood from HIV-1-negative source patients
and nine to blood from HIV-positive pa-
tients.
Demographic HCW data included age,
sex, occupation, and other possible expo-
sures to HIV-1 besides occupational expo-
sure. Source patient data included presence
or absence of symptoms, peripheral blood
CD4 T cell counts and plasma viral load and
clinical outcome over two months of follow-
up after the episode. The accident was char-
acterized by the type of device involved
(scalpel, hollow or solid needle), presence of
blood, and use of gloves by the HCW. The
use of prophylactic AZT was also recorded.
HCW were followed up for 6 months. Plasma
viral loads and antibody testing for HIV-1
(ELISA) were performed at days 0, 30, 90,
and 180 after exposure.
For the induction of IL-10, in vitro blood
samples were collected over a period of six
months after exposure, and PBMC were ob-
tained by gradient centrifugation over Ficoll
(Pharmacia-Biotech, Uppsala, Sweden).
PBMC were resuspended at 2 x 106 cells/ml
in RPMI 1640 medium (Sigma, St. Louis,
MO, USA) supplemented with 10% autolo-
gous serum. Medium was used as negative
control, whereas the phytohemagglutinin
(PHA) stimulus was considered as positive
control. For HIV-specific stimulation we used
an ELISA plate coated with HIV-1 antigens
(Hemobio HIV-1, Embrabio, São Paulo, SP,
Brazil). This plate was successfully used for
the induction of HIV-1 antibody production
in vitro (10), and in our experience has per-
mitted us to discriminate HIV-positive pa-
tients from seronegative healthy volunteers.
We tested 23 HIV-positive asymptomatic
patients taking no antiretroviral treatment,
and 21 HIV-seronegative healthy volunteers
and found HIV-induced IL-10 to be higher in
HIV-positive patients (median 34.6 pg/ml,
range 0-242 pg/ml) than in healthy volun-
teers (median 0 pg/ml, range 0-61 pg/ml)
(P = 0.0008, Mann-Whitney test). Superna-
tants were collected after 48 h of incubation
at 37ºC in a 5% CO2 atmosphere. Induction
of IL-10 was considered to be HIV-specific
when the levels obtained by HIV stimulation
were at least two times that of the negative
control.
IL-10 was measured in the supernatants
by ELISA. Monoclonal antibodies and re-
combinant IL-10 were obtained from Phar-
Mingen (San Jose, CA, USA). Samples from
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the same HCW were tested simultaneously.
The sensitivity of the test was 5 pg/ml.
Plasma load of HIV RNA was quanti-
tated using the Nucleic Acid-Based Amplifi-
cation System (Organon Teknika, Boxtel,
The Netherlands) according to manufacturer
instructions. The lowest detection limit was
400 copies/ml.
No HIV seroconversion or positive RNA
viral load was detected among the HCW
enrolled in the study.
Among the six HIV-positive source pa-
tients, five had AIDS and two died 2 months
after exposure. One HIV-positive patient was
the source patient of four HCW enrolled in
this study. There was visible blood in all
accidents. The HCW were always using la-
tex gloves and in two instances were using
double gloves when the injury occurred.
Tables 1 and 2 show the levels of IL-10
after HIV stimulation, as well as values for
negative (medium) and positive control
(PHA) in HCW exposed to HIV-1-positive
and HIV-1-negative source patients. PHA-
Table 1. Detection of IL-10 in supernatants of PBMC from health care workers (HCW) exposed to an HIV-
positive source patient at the time of exposure and during follow-up.
HCW T0 T1 T3 T6
Ctl HIV PHA Ctl HIV PHA Ctl HIV PHA Ctl HIV PHA
1    - - - nd nd 96.6 23.6 21.2 172.9 nd 22.8 324.5
2 - - - - - - 45.4 146.8 750.9 - - -
3 - - - - - nd  nd 263.0 121.1 97.0 911.9
4 - - - nd nd 114.0 - - - nd nd 146.9
5 - - - - - - 21.6 32.9 269.6 nd 120.7 301.8
6 7.2 4.2 1589.2 26.7 115.4 386.6 nd nd 125.8 10.2 21.4 527.1
7 109.6 113.4 945.6 102.1 105.0 794.9 - - - 13.4 12.5 535.8
8 - - - nd 3.7 660.0 - - - 105.9 107.6 236.0
9 - - - - - - nd 56.1 899.3 10.5 94.6 830.2
Data are reported as pg/ml. Values in bold indicate a positive response to HIV-1 antigens (2-fold increase over
control). - = not measured; nd = not detectable; Ctl = negative control (medium); PHA = positive control
(phytohemagglutinin stimulus); T0, T1, T3 and T6: baseline and 1, 3 and 6 months after exposure.
Table 2. Detection of IL-10 in supernatants of PBMC from health care workers (HCW) exposed to an HIV-
negative source patient at the time of exposure and during follow-up.
HCW T0 T1 T3 T6
Ctl HIV PHA Ctl HIV PHA Ctl HIV PHA Ctl HIV PHA
1 - - - 199.1 147.2 711.0 12.8 14.2 178.8 - - -
2 - - - 11.8 12.3 330.8 16.9 13.9 223.7 nd nd 23.6
3 - - - nd nd 1117.0 3.7 21.6 662.9 - - -
4 nd nd 832.1 52.6 54.3 1257.8 - - - nd nd 950.4
5 17.2 88.0 147.8 146.5 167.8 902.5 - - - nd nd 356.5
6 139.8 160.3 1861.7 120.5 135.2 2178.0 121.4 113.0 2157.1 102.5 103.1 1132.1
7 233.5 284.9 4334.1 - - - 117.2 113.4 2671.6 105.9 107.6 236.0
8 52.4 85.4 1224.7 - - - 44.2 66.3 338.4 - - -
9 - - - - - - nd nd 384.1 - - -
Data are reported as pg/ml. Values in bold indicate a positive response to HIV-1 antigens (2-fold increase over
control). - = not measured; nd = not detectable; Ctl = negative control (medium); PHA = positive control
(phytohemagglutinin stimulus); T0, T1, T3 and T6: baseline and 1, 3 and 6 months after exposure.
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induced IL-10 did not differ between HCW
groups. Five of nine HCW exposed to an
HIV-1-positive source patient had detect-
able HIV-induced IL-10 (100% increase over
negative control). In one exposed individual,
positive results were obtained in samples
collected 1 and 6 months after exposure; in
two the positive sample was collected at 6
months. The fourth exposed HCW had posi-
tive results at months 3 and 6, and the last
one at month 3 (Table 1). Two of nine HCW
exposed to an HIV-negative source patient
also had detectable levels of HIV-induced
IL-10, one in the sample collected on the day
of occupational exposure and the other in the
sample collected at 3 months (Table 2).
Among the accidents involving HIV-posi-
tive source patients in this study, four HCW
were exposed to the same asymptomatic pa-
tient (HCW 1, 2, 3 and 4; Table 1) and five to
other AIDS patients. Induction of IL-10 was
observed in two of the former and in three of
the latter. CD4 and viral load were obtained
from only a small proportion of HIV-1-posi-
tive source patients, which precludes any
analysis of the correlation of these param-
eters and HIV-induced IL-10 in recipient
HCW. Five HCW did not receive antiretro-
viral post-exposure prophylaxis and four re-
ceived AZT. IL-10 was found in three HCW
of the first group and in two of the second
one. The type of device involved in the
injury differed between HCW exposed to an
HIV-positive source that had HIV-induced
IL-10 production and those without HIV-
induced IL-10 production. The devices in-
volved in the accidents without IL-10 pro-
duction were solid needles (HCW 3 and 4) or
needles used for digital punctures for deter-
mination of glucose levels (HCW 7 and 8).
The devices involved in the accidents of the
five HCW with HIV-induced IL-10 produc-
tion were scalpels (HCW 2) or hollow-bore
needles used for phlebotomy (HCW 1, 5, 6,
9) (Table 1).
The results of this study show that pro-
duction of HIV-1-induced IL-10 was found
in five of nine HCW exposed to HIV-1-
contaminated blood and in two of nine HCW
exposed to HIV-negative blood. In the first
group IL-10 induction was mainly observed
between 3 and 6 months after exposure. One
HCW of the second group had a positive
result in the sample obtained on the day of
exposure. Thus, this result may be consid-
ered as a) false positive, b) not related to the
accident, or c) perhaps related to another
previous exposure.
These findings agree with studies that
reported HIV-induced IL-2 production in
75% of HCW occupationally exposed to
HIV compared to 24% in the control group
(4). CTL activity has also been shown in
35% of exposed subjects and in no subject of
the control group (5).
In a case-control study, Cardo et al. (2)
showed that increased risk for HIV infection
after blood exposure is related to a larger
volume of blood and, possibly, a higher HIV
load in the source patient’s blood.
In our study, we observed that the medi-
cal devices involved in HCW injuries with
HIV-positive source patients differed be-
tween those with HIV-induced IL-10 and
those without HIV-induced IL-10. In the
first group percutaneous exposure involved
either hollow-bore needles used for phle-
botomy or a scalpel. In the latter group occu-
pational exposure was by solid needle or by
hollow-bore needles used for digital punc-
ture. Thus, if we assume that the former
group was exposed to a larger amount of
blood, a correlation between large blood
volumes and IL-10 may be considered. This
hypothesis is supported by the findings of
the cluster of the four HCW exposed to the
same HIV-1-infected source patient. Inter-
estingly, in this cluster, HIV-induced IL-10
was seen in two HCW with either lancet
injuries (HCW 2) or solid plus hollow-bore
needle injuries (HCW 1), but was not seen in
the other two HCW (HCW 3 and 4) whose
injuries involved solid needles. No other
correlation was seen between the character-
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istic of the exposure and IL-10 production.
In all cases HCW were using gloves and
bleeding was present.
The role of IL-10 in HIV-1 infection
remains controversial. It is likely that, by
down-regulating proinflammatory cytokines,
IL-10 inhibits HIV-1 replication. It was ob-
served that IL-10 is produced during HIV-1
infection and that IL-10 inhibits viral repli-
cation in macrophages in vitro (8,11,12). On
the other hand, the enhancement of virus
replication is also attributed to IL-10 (9). It
has been suggested that, in amounts not large
enough to inhibit TNF-α, IL-10 may in-
crease virus replication. Moreover, it has
also been shown that IL-10 may be impor-
tant in cellular immune dysfunction in HIV-
infected patients (13).
The demonstration of HIV-induced
IL-10 in HCW occupationally exposed to
HIV-1 in this study supports the idea that
specific immune responses are seen at much
higher rates than seroconversion. The role of
IL-10 in this setting remains to be estab-
lished.
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